Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 24 – 26 April 2023
Seven new medicines recommended for approval EMA’s human medicines committee (CHMP) recommended seven medicines for approval at its April 2023 meeting. The CHMP recommended granting a marketing authorisation for Arexvy (recombinant, adjuvanted), the first vaccine for active immunisation to protect…